These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10257087)

  • 1. The marketing of a drug.
    Wolfe SM
    Health Med; 1982; 1(2):31-2. PubMed ID: 10257087
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
    Cheng CM; Shin J; Guglielmo BJ
    JAMA Intern Med; 2014 Oct; 174(10):1704-5. PubMed ID: 25127107
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety.
    Qato DM; Alexander GC
    JAMA; 2011 Oct; 306(14):1595-6. PubMed ID: 21990303
    [No Abstract]   [Full Text] [Related]  

  • 4. US consumer group criticizes proposal to allow drug makers to challenge safety information.
    McCarthy M
    BMJ; 2015 Mar; 350():h1514. PubMed ID: 25784706
    [No Abstract]   [Full Text] [Related]  

  • 5. US lawmakers tackle safety reforms at the FDA.
    Zwillich T
    Lancet; 2007 Jun; 369(9578):1989-90. PubMed ID: 17577942
    [No Abstract]   [Full Text] [Related]  

  • 6. A pre-marketing ALT signal predicts post-marketing liver safety.
    Moylan CA; Suzuki A; Papay JI; Yuen NA; Ames M; Hunt CM
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):433-9. PubMed ID: 22668747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lifecycle approach to the evaluation of FDA approval methods and regulatory actions: opportunities provided by a new IOM report.
    Psaty BM; Meslin EM; Breckenridge A
    JAMA; 2012 Jun; 307(23):2491-2. PubMed ID: 22563032
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-marketing surveillance of prescription drug safety: past, present, and future.
    Chen BK; Yang YT
    J Leg Med; 2013; 34(2):193-213. PubMed ID: 23980746
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA Safety and Innovation Act.
    Steinbrook R; Sharfstein JM
    JAMA; 2012 Oct; 308(14):1437-8. PubMed ID: 23047356
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular basis of drug-induced immunological liver injury.
    Van Pelt FN; Straub P; Manns MP
    Semin Liver Dis; 1995 Aug; 15(3):283-300. PubMed ID: 7491507
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovering adverse drug reactions.
    Lasagna L
    JAMA; 1983 Apr 22-29; 249(16):2224-5. PubMed ID: 6339764
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting drug side effects: signals and noise.
    Avorn J
    JAMA; 1990 Apr; 263(13):1823. PubMed ID: 2313853
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-marketing surveillance or drug acceptability study?
    Barnett DB; Woods KL
    Br J Clin Pharmacol; 1987 Sep; 24(3):281-2. PubMed ID: 3663444
    [No Abstract]   [Full Text] [Related]  

  • 14. The report of the Institute of Medicine on drug safety.
    Somberg J
    Am J Ther; 2007; 14(1):1-2. PubMed ID: 17303967
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with a failed postmarketing drug surveillance program.
    Hollister LE; Overall JE
    J Clin Pharmacol; 1984 Jan; 24(1):3-5. PubMed ID: 6707232
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
    Kuehn BM
    JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108
    [No Abstract]   [Full Text] [Related]  

  • 17. Ticrynafen recalled.
    FDA Drug Bull; 1980 Feb; 10(1):3-4. PubMed ID: 7358240
    [No Abstract]   [Full Text] [Related]  

  • 18. US judge fines Johnson & Johnson $1.1bn for misleading marketing of risperidone.
    Tanne JH
    BMJ; 2012 Apr; 344():e2772. PubMed ID: 22508952
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmarketing surveillance for drug safety.
    Holden WL; Scarazzini LJ
    Clin Pharmacol Ther; 2004 Nov; 76(5):503; author reply 504-5. PubMed ID: 15536464
    [No Abstract]   [Full Text] [Related]  

  • 20. Mandatory post marketing studies.
    Somberg J
    Am J Ther; 2007; 14(4):321. PubMed ID: 17667203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.